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A beta-lactam-sensitive strain (C152) of Shigella dysenteriae showed two major outer membrane proteins
(OMPs) with Mrs of 43,000 and 38,000, while the clinical isolate M2 lacked the 43,000-Mr OMP, which acted
as a channel for beta-lactam antibiotics. Permeability of beta-lactams across the outer membrane (OM) of M2
was lower than that across the OM of C152. Mutants deficient in the 43-kDa OMP could be selected in vitro
from strain C152 in the presence of cefoxitin. All beta-lactam-resistant strains were sensitive to imipenem.
Shigella species represent a major cause of diarrheal diseases
in developing countries (2). The frequency of strains multiply
resistant to ampicillin, trimethoprim-sulfamethoxazole, strep-
tomycin, chloramphenicol, and tetracycline is a cause of grow-
ing concern (2, 4). Resistance to antibiotics may arise through
alteration of the drug targets (26), degradation of the drugs by
enzymes such as the beta-lactamases (10), decrease in perme-
ability of the cell envelope (8, 9, 14, 16, 23, 25), and extrusion
of the drugs by efflux pumps of broad specificity (17). The
permeability factor controlling the access of the antibiotic to its
target is often critical in determining the efficacy of a beta-
lactam against a gram-negative bacterium (18). We demon-
strate here the association of beta-lactam resistance with the
absence of a 43-kDa porin in Shigella dysenteriae.
Clinical isolates of sensitive (C152) and resistant (M2)
strains of S. dysenteriae type I were obtained from the School of
Tropical Medicine, Calcutta, India. The organisms were grown
routinely in tryptic soy broth (Difco) at 37°C. The antimicro-
bial agents tested were cephaloridine, moxalactam, cefoxitin,
and norfloxacin (Sigma, St. Louis, Mo.); tetracycline and chlor-
amphenicol (Boehringer Mannheim); imipenem (gift from
Jean-Marie Frere, University of Liege, Liege, Belgium); and
aztreonam (gift from Bristol-Myers Squibb, Syracuse, N.Y.).
MICs were determined by growing organisms in twofold serial
dilutions of the antibiotics on Mueller-Hinton agar plates. A
total of 106 CFU was spotted onto agar plates supplemented
with antibiotics, and MICs were read after 18 h of incubation
at 37°C. The concentration at which no visible growth was
observed was recorded as the MIC. Cefoxitin-resistant mutants
were isolated by adapting strain C152 to serially increasing
concentrations of cefoxitin on Luria agar plates. Colonies
growing at a particular concentration of cefoxitin were plated
at the same concentration of antibiotic three times in succes-
sion before adaptation in the presence of the next twofold-
higher concentration of cefoxitin.
For preparing outer membranes (OMs), cells were har-
vested, washed with 50 mM Tris-HCl–5 mM EDTA (pH 8)
containing 1-mg/ml DNase, and disrupted by sonication (Lab-
sonic 2000; Braun, Melsungen, Germany) with four 1-min
pulses at 100 W. Undisrupted cells and cell debris were re-
moved by centrifugation. Membranes were then pelleted by
centrifugation at 16,000 3 g for 30 min as described previously
(12), treated with 2% Sarkosyl for 60 min at 30°C, and centri-
fuged at 100,000 3 g for 30 min. The pellet which contained
the outer membrane proteins (OMPs) was washed twice with
0.5% Sarkosyl and extracted successively with 1% (wt/vol)
CHAPS {3-[(3-cholamidopropyl)-dimethylammonio]-1-pro-
panesulfonate} in the presence of 0.5 M NaCl overnight at 4°C
and with 2% (wt/vol) Nonidet P-40 for 1 h at 30°C, followed by
centrifugation at 100,000 3 g for 40 min. The pellet was then
treated with 2% (wt/vol) N-dodecyl-N,N-dimethyl-3-ammonio-
1-propanesulfonate (Zwittergent 3-12) overnight at 4°C and
centrifuged as before. The supernatant was dialyzed against 20
mM Tris-HCl–5 mM EDTA containing 0.1% Zwittergent 3-12
(pH 8) (buffer A), and 0.7 mg of protein was loaded on a Mono
Q HR5/5 (1-ml) column connected to a fast protein liquid
chromatography system and equilibrated in buffer A. The pro-
tein was eluted with a gradient of 0 to 0.7 M NaCl at a flow rate
of 1 ml/min. Fractions were analyzed by sodium dodecyl sul-
fate-polyacrylamide gel electrophoresis (SDS-PAGE) accord-
ing to the method of Laemmli (7). For better resolution of the
OMPs, 3 M urea was included in the gels (11). Fractions
containing mainly the 43-kDa OMP were pooled and stored
for further use.
Liposome swelling assays were carried out as described by
Nikaido and Rosenberg (20). A total of 2.5 mmol of egg phos-
phatidylcholine and 0.1 mmol of dicetyl phosphate were dried
as a thin film. The film was suspended in 0.2 ml of buffer to
which crude OM (100 mg of protein) or purified 43-kDa pro-
tein (25 mg) was added. The mixture was sonicated and dried
under vacuum. Finally, the film was reconstituted with 0.4 ml
of a solution containing 12 mM stachyose, 4 mM sodium NAD,
and 1 mM imidazole-NAD buffer (pH 6) (9, 19) and diluted in
isotonic solutions of beta-lactams. Liposome swelling was mea-
sured as the initial rate of decrease in absorbance at 400 nm.
The concentration of stachyose used was isotonic for the above
liposomes. The isotonic concentration of stachyose as well as
that of the beta-lactam antibiotic used was determined as de-
scribed by Yoshimura and Nikaido (28).
Beta-lactamase activity was assayed spectrophotometrically
at 482 nm (21) with the chromogenic cephalosporin nitrocefin
(Becton Dickinson Microbiology Systems, Cockeysville, Md.),
with sonic extracts of exponentially growing cells. For penicillin
binding assays, 100 mg of membrane proteins was incubated
with 1023 M benzyl[14C]penicillin (0.5 mCi/mmol) (Amersham
International, Buckinghamshire, United Kingdom) at 30°C for
10 min (12). The labeling was terminated with a 10-fold excess
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of nonradioactive penicillin. Membranes were analyzed by
SDS-PAGE, followed by fluorography. In competition studies,
membranes were first incubated for 10 min at 30°C with the
nonradioactive beta-lactam, followed by incubation for 10 min
with a saturating concentration (1024 M) of benzyl[14C]peni-
cillin and termination of the reaction after 10 min as usual. For
determination of the 90% inhibitory doses (ID90), the intensi-
ties of the bands were analyzed by densitometric scanning of
the fluorograms.
Automated N-terminal peptide sequencing with purified
protein was performed on a Shimadzu PSQ-1 protein se-
quencer.
OM profiles and susceptibilities of the different strains of S.
dysenteriae to beta-lactam and other antibiotics. On SDS-urea
gels, S. dysenteriae C152 was found to contain two major pro-
spective pore-forming proteins of 43,000 and 38,000 in Mr (Fig.
1). The clinical isolate M2 showed an almost complete absence
of the 43-kDa OMP. Adaptation of C152 in the presence of
cefoxitin in vitro gave rise to two porin-deficient mutants, M3
(with an OM profile similar to that of M2) and M7 (which
showed a partial lack of the 43-kDa OMP in comparison to
C152) (Fig. 1). With reference to C152, the 43-kDa-OMP-
deficient strains M2, M3, and M7 were all resistant to a range
of beta-lactams (Table 1). Interestingly, however, all four
strains were sensitive to the carbapenem, imipenem. The sen-
sitivity to the structurally unrelated antibiotics tetracycline,
chloramphenicol, and norfloxacin was the same among all four
strains.
Susceptibilities of the PBPs towards beta-lactam antibiotics
and beta-lactamase activities. The penicillin-binding protein
(PBP) profiles of all the strains were identical and similar to
that reported earlier for S. dysenteriae (reference 12 and data
not shown). There were no observable changes in the affinities
of the PBPs of M2 or M7 compared to those of C152 in the
case of antibiotics to which these strains were resistant (Table
2) with the exception of moxalactam, which appeared to have
a higher affinity for PBP3 of C152 and M7 compared to that of
M2. The beta-lactamase levels in all the strains were very low
(#2 nmol of nitrocefin hydrolyzed/min/mg of protein), and no
beta-lactamase could be induced in the presence of the beta-
lactams tested.
The 43-kDa porin as a channel for beta-lactam antibiotics.
The 43-kDa porin was purified from the OM of S. dysenteriae
C152 and was greater than 98% pure (Fig. 1). It had the
N-terminal sequence AEVYNKD-N, which was typical of
other enterobacterial porins (1). Permeabilities of beta-lactam
antibiotics were measured with proteoliposomes containing
crude OMs or purified porin. M2 showed a lower permeability
in the case of piperacillin, cephaloridine, moxalactam, cefox-
itin, and aztreonam compared to C152 (Table 3). Imipenem
permeabilities of the two strains were comparable. M3, which
FIG. 1. SDS-PAGE of OMPs of S. dysenteriae C152 (lane 1), M2 (lane 2), M3
(lane 3), and M7 (lane 4) (A) and purified 43-kDa porin (B).
TABLE 1. Susceptibilities of different strains of S. dysenteriae
towards beta-lactam and other antibiotics
Antibiotic
MIC (mg/ml) for strain:
C152 M2 M3 M7
Cephaloridine 4 80 80 100
Cefoxitin 5 1,000 1,000 1,000
Moxalactam 8 500 125 125
Piperacillin 8 1,000 1,000 1,000
Aztreonam 0.5 500 500 125
Imipenem 2 2 2 2
Tetracycline 200 200 200 200
Chloramphenicol 250 250 250 250
Norfloxacin 0.3 0.3 0.3 0.3
TABLE 2. Binding of different beta-lactam antibiotics to the PBPs
of S. dysenteriae, represented as ID90 (mM)
a
Antibiotic Strain PBP1 PBP2 PBP3 PBP5
Cephaloridine C152 100 .100 .100 .100
M2 100 .100 .100 .100
M7 100 .100 .100 .100
Cefoxitin C152 100 .100 .100 1
M2 100 .100 .100 1
M7 100 .100 .100 1
Aztreonam C152 .100 .100 5 .100
M2 .100 .100 5 .100
M7 .100 .100 5 .100
Piperacillin C152 .100 .100 5 .100
M2 .100 .100 5 .100
M7 .100 .100 5 .100
Imipenem C152 .100 5 .100 .100
M2 .100 5 .100 .100
M7 .100 5 .100 .100
Moxalactam C152 .100 .100 1 .100
M2 .100 .100 10 .100
M7 .100 .100 1 .100
a ID90 represents the concentration of beta-lactam antibiotic that reduces the
binding of benzyl[14C]penicillin by 90%. Results are the means of three deter-
minations (standard deviation, #10%).
TABLE 3. Swelling rates of proteoliposomes reconstituted with
OMPs from M2
Antibiotic Relativeswelling ratea
Cephaloridine ........................................................................ 50 (40–59)
Cefoxitin ................................................................................. 50 (42–59)
Moxalactam............................................................................ 59 (54–65)
Piperacillin ............................................................................. 50 (43–57)
Aztreonam.............................................................................. 60 (52–69)
Imipenem ...............................................................................100 (95–108)
a For each antibiotic, results are expressed as percentages of the swelling rate
of liposomes reconstituted with OMs of C152. Data represent the averages of
four sets of experiments performed with four different OM preparations. The
ranges of values obtained are listed in parentheses.
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has an antibiotic susceptibility profile similar to that of M2,
showed, like this strain, almost no 43-kDa porin in SDS-urea
gels. M7, which showed a partial lack of the 43-kDa porin, was
also less susceptible than C152 to the antibiotics tested. A
partial lack of the 43-kDa porin therefore appeared sufficient
to confer high-level beta-lactam resistance to poorly perme-
able beta-lactams. With proteoliposomes containing the puri-
fied 43-kDa porin, this protein was confirmed to act as a chan-
nel for beta-lactams. Relative swelling rates, calculated as
percentages of the rate of swelling of cephaloridine, were 50,
30, 15, and 5 for cefoxitin, moxalactam, aztreonam, and piper-
acillin, respectively. Permeability was, therefore, low in the
case of the dianionic compounds aztreonam and moxalactam
and more so in the case of piperacillin, which has a bulky side
chain.
Antibiotic insensitivity is often associated with intrinsic low
permeability of hydrophilic antibiotics through the porin chan-
nels, as in the case of Pseudomonas aeruginosa (15), or by the
lack of expression of nonspecific porin channels (22, 27). In S.
dysenteriae, the absence of the 43-kDa porin affected largely
the susceptibility to slowly penetrating beta-lactams such as the
dianionic moxalactam and aztreonam, as well as piperacillin,
which has an extremely bulky side chain. This was not surpris-
ing since earlier reports have shown that Escherichia coli K-12
mutants that were highly resistant to moxalactam or dibasic
beta-lactams were only slightly more resistant to more perme-
able antibiotics such as cephaloridine, cephacetrile, and ampi-
cillin (5, 6). The OM penetration step is likely to comprise the
rate-limiting step in the action of slowly penetrating antibiotics
in S. dysenteriae, accounting for the high-level resistance of M2
to these antibiotics, compared to that of C152. The absence of
cross-resistance to other classes of antibiotics suggests that
efflux pumps (which confer multiple antibiotic resistance) are
unlikely to be involved in the resistance mechanism of these
mutants.
For Enterobacter cloacae, imipenem- and meropenem-resis-
tant mutants have been reported to lack nonspecific porins
(24). On the other hand, the absence of nonspecific porins does
not directly correlate with the imipenem susceptibility of En-
terobacter aerogenes (3). In S. dysenteriae, the absence of the
43-kDa porin was not sufficient to confer imipenem resistance,
similar to the case of Klebsiella pneumoniae, for which mutants
selected in vivo were resistant to cefoxitin, whereas imipenem
maintained activity in these porin-deficient mutants (13). The
speculation that there is an alternative pathway for uptake of
carbapenems in S. dysenteriae is supported by the fact that
imipenem permeabilities were comparable in C152 and M2.
However, the imipenem channel, if any, remains to be identi-
fied.
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